PrPSc detection in formalin-fixed paraffin-embedded tissue by ELISA
- Eric M Nicholson1Email author,
- Justin J Greenlee1 and
- Amir N Hamir1, 2
https://doi.org/10.1186/1756-0500-4-432
© Nicholson et al; licensee BioMed Central Ltd. 2011
Received: 6 September 2011
Accepted: 21 October 2011
Published: 21 October 2011
Abstract
Background
Formalin-fixed paraffin-embedded tissue is regularly employed in the diagnosis of transmissible spongiform encephalopathies (TSE) by immunohistochemistry (IHC), the standard by which all other TSE diagnostic protocols are judged. While IHC affords advantages over diagnostic approaches that typically utilize fresh or frozen tissue, such as Western blot and ELISA, the process of fixing, staining, and analyzing individual sections by hand does not allow for rapid or high throughput screening. However, preservation of tissues in formalin is not dependent upon the availability of refrigeration.
Findings
Formalin-fixed paraffin-embedded tissues from TSE transmission studies of scrapie in sheep, chronic wasting disease in white-tailed deer or transmissible mink encephalopathy in cattle were cut at 5 μm thickness. Samples containing the tissue equivalent of as little as one 5 μm section can be used to readily discriminate positive from negative samples.
Conclusions
This approach cannot replace IHC but may be used along with IHC as both a more rapid and readily high throughput screen where fresh or frozen tissues are not available or impractical.
Keywords
Findings
Due to the lack of a defined immune response or nucleic acid component of the infectious agent, approaches for transmissible spongiform encephalopathy (TSE) diagnosis rely upon methods of immunodetection including immunohistochemistry (IHC), Western blotting and enzyme-linked immunosorbent assay (ELISA)-based approaches for detection of the infectious agent. [1–3] Generally speaking, IHC relies upon formalin fixed paraffin embedded tissues, while Western blotting and ELISA utilize fresh or frozen tissues. Recently, methods have been reported that allow detection of PrPSc in formalin fixed tissues by Western blot [4–6]. Here we report an extension of this approach to allow ELISA-based detection of PrPSc in formalin-fixed paraffin-embedded tissues.
Tissue samples
This study utilized archived paraffin-embedded tissue samples from studies of scrapie in sheep, chronic wasting disease (CWD) in white-tailed deer (WTD) and transmissible mink encephalopathy (TME) in cattle as part of TSE research conducted at the National Animal Disease Center-USDA-ARS (Ames, IA). Animals were cared for and euthanized under National Animal Disease Center approved institutional animal care and use protocols. Samples were collected in 10% neutral buffered formalin prior to standard processing into paraffin blocks, with time in formalin ranging from 7 days to ~450 days. Previous studies of formalin fixed tissues report a marked sensitivity decrease for Western blots on tissues left in formalin for 2 or more years [6]. Based on this observation we limited our analysis to samples with fixation times less than 2 years.
Sample preparation
The method described here is an extension of previously published methods for Western blotting of formalin-fixed paraffin embedded samples differing only in the method for detecting PrPSc[4, 5]. As previously described, four 5 μm thick tissue sections from each paraffin block were collected into a 1.5 ml centrifuge. To each tube, 150 μl of 0.05 M Tris (pH 7.5), 1 mM EDTA, and 0.5% Tween 20 was added. The tube was placed at 100°C for 10 min and immediately placed into a dry ice ethanol slurry until frozen. The 10 min boil/freeze cycle was repeated once. The sample was brought to 100°C for an additional 10 min and immediately centrifuged at 3,000 × g for 10 min to separate the paraffin from the aqueous phase while also pelleting the tissue. In the event that the separation of paraffin was incomplete, the tube was reboiled for 10 min and the centrifugation step repeated. The aqueous layer including the tissue pellet was transferred to a clean 1.5 ml tube. At this point, the sample volumes were approximately 120 μl. Tissue disruption by sonication was done in 30 intervals of 40 sec with brief vortex mixing between sonication steps in a bath sonicator filled with ice water.
Sample Analysis
Following tissue disruption, 100 μL was removed and placed in a clean tube. From this 100 μl sample, a 20 μL sample was used to detect the presence of PrPSc using the IDEXX HerdChek Bovine Spongiform Encephalopathy-Scrapie Antigen Test Kit ELISA by incorporating the 20 μl sample in place of the 120 μl of tissue homogenate called for in the manufacturer's instructions. The remaining 80 μl was enriched by centrifugation at 186,000 × g for 55 minutes. The supernatant was removed and 20 μl analyzed using the HerdChek kit as described previously. The pellet was resuspended in 20 μl of 0.05 M Tris (pH 7.5), 1 mM EDTA, and 0.5% Tween 20 and analyzed as described above for both the supernatant and the unenriched sample.
Results and Discussion
Detection of PrPSc in Formalin Fixed Paraffin Embedded Tissues by ELISA.
TSE (species) | Animal # | Supernatant | Unenriched | Enriched |
|---|---|---|---|---|
Scrapie (Sheep) | 23 | 0.074 | 0.76 | 2.8 |
3503 | 0.11 | 0.61 | 2.40 | |
3515 | 0.096 | 0.203 | 1.36 | |
3740 | 0.056 | 0.19 | 0.73 | |
3742 | 0.061 | 0.31 | 1.71 | |
3506 | 0.064 | 0.42 | 1.27 | |
Neg (Sheep) | 0009 | 0.064 | 0.063 | 0.062 |
0007 | 0.083 | 0.067 | 0.074 | |
3527 | 0.098 | 0.10 | 0.13 | |
0050 | 0.077 | 0.059 | 0.062 | |
0059 | 0.074 | 0.059 | 0.058 | |
0004 | 0.089 | 0.031 | 0.089 | |
CWD (WTD) | 628 | 0.083 | ND | 0.459 |
632 | 0.08 | ND | 0.322 | |
648 | 0.084 | ND | 0.971 | |
654 | 0.086 | ND | 1.15 | |
Neg (WTD) | 645 | 0.085 | ND | 0.079 |
681 | 0.075 | ND | 0.080 | |
TME (Cattle) | 520 | 0.07 | 0.211 | 0.508 |
521 | 0.069 | 0.210 | 0.618 | |
522 | 0.073 | 0.162 | 0.571 | |
524 | 0.060 | 0.233 | 1.302 | |
526 | 0.065 | 0.281 | 0.650 | |
Neg (Cattle) | 523 | 0.074 | 0.071 | 0.066 |
525 | 0.074 | 0.085 | 0.077 | |
527 | 0.072 | 0.084 | 0.072 |
The absence of detectible PrPSc in the supernatant is consistent with the numeric values of the enriched samples exhibiting a higher signal than the corresponding samples prior to enrichment. Enriched samples were derived from samples 4 times larger than unenriched samples, but signal from enriched samples were not always 4 times greater. Deviations from an actual 4-fold increase in signal as would be expected for the increased concentration were generally small and likely reflect non-linearity of the signal over the detection range or a less than complete recovery in the enrichment centrifugation step or both.
In one instance, an unenriched cattle TME sample was determined to be below the positive cutoff value, however, the enriched sample was clearly positive. Based upon this and the overall enhancement of sensitivity, our recommendations for use of this method include incorporation of the 186,000 × g centrifugation based enrichment.
Of note is that the IDEXX ELISA utilizes a proprietary capture ligand (Seprion ligand) rather than an antibody [7]. This capture ligand binds misfolded PrPSc protein. Thus, PrPSc must retain the characteristics of a misfolded protein through the fixation process and the enrichment processing described here or it would not bind the capture surface.
In summary, ELISA based detection of PrPSc from formalin-fixed paraffin-embedded tissue is a rapid means to detect PrPSc with the potential for hundreds of sample to be analyzed by an individual in a single day. The detection approach is distinct from IHC and offers the diagnostic and research community an additional tool to detect PrPSc.
Declarations
Acknowledgements
The authors thank Trudy Tatum, Martha Church, and Leisa Mandell for excellent technical support and Dr. Marcus Kehrli for critical evaluation of the manuscript. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.
Authors’ Affiliations
References
- International Office of Epizootics. Biological Standards Commission: Chapter 2.4.6 Bovine spongiform encephalopathy. Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. 2008, Office international des epizooties, Paris, 6Google Scholar
- Prusiner SB, Scott MR, DeArmond SJ, Cohen FE: Prion protein biology. Cell. 1998, 93: 337-348. 10.1016/S0092-8674(00)81163-0.PubMedView ArticleGoogle Scholar
- Schaller O, Fatzer R, Stack M, Clark J, Cooley W, Biffiger K, Egli S, Doherr M, Vandevelde M, Heim D, Oesch B, Moser M: Validation of a Western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol (Berl). 1999, 98: 437-443. 10.1007/s004010051106.View ArticleGoogle Scholar
- Kunkle RA, Nicholson EM, Lebepe-Mazur S, Orcutt DL, Srinivas ML, Greenlee JJ, Alt DP, Hamir AN: Western blot detection of PrPSc in archived paraffin-embedded brainstem from scrapie-affected sheep. J Vet Diagn Invest. 2008, 20: 522-526. 10.1177/104063870802000421.PubMedView ArticleGoogle Scholar
- Nicholson EM: Enrichment of PrPSc in formalin-fixed, paraffin-embedded tissues prior to analysis by Western blot. J Vet Diagn Invest. 2011, 23: 790-792. 10.1177/1040638711407886.PubMedView ArticleGoogle Scholar
- Nicholson EM, Kunkle RA, Hamir AN, Lebepe-Mazur S, Orcutt D: Detection of the disease-associated isoform of the prion protein in formalin-fixed tissues by Western blot. J Vet Diagn Invest. 2007, 19: 548-552. 10.1177/104063870701900515.PubMedView ArticleGoogle Scholar
- Lane AS, Christoper J, Stephen Dealler, Wilson Stuart M: Polymeric Ligands with Specificty for Aggregated Prion Proteins. Clincal Chemistry. 2003, 49: 1174-1775.Google Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
